相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Anticancer Ruthenium(η6-p-cymene) Complexes of Nonsteroidal Anti-inflammatory Drug Derivatives
Farhana Aman et al.
ORGANOMETALLICS (2014)
Breakthrough for a DNA break-preventer
Richard D. Wood et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Robert Trondl et al.
CHEMICAL SCIENCE (2014)
Mitochondria-mediated apoptosis in mammals
Shunbin Xiong et al.
PROTEIN & CELL (2014)
Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments
Evyenia Shaili
SCIENCE PROGRESS (2014)
Reevesioside F induces potent and efficient anti-proliferative and apoptotic activities through Na+/K+-ATPase α3 subunit-involved mitochondrial stress and amplification of caspase cascades
She-Hung Chan et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Mitochondria: gatekeepers of response to chemotherapy
Kristopher A. Sarosiek et al.
TRENDS IN CELL BIOLOGY (2013)
Interactions of DNA with a New Platinum(IV) Azide Dipyridine Complex Activated by UVA and Visible Light: Relationship to Toxicity in Tumor Cells
Jitka Pracharova et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Single Crystal EPR of the Mixed-Ligand Complex of Copper(II) with L-Glutamic Acid and 1,10-Phenanthroline: A Study on the Narrowing of the Hyperfine Structure by Exchange
Nicolas I. Neuman et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2012)
Rapid Access to Substituted Piperazines via Ti(NMe2)4-Mediated C-C Bond-Making Reactions
Zhou Chen et al.
ORGANOMETALLICS (2012)
Bis(hydrogen L-glutamato)palladium(II)
Antje Seifert et al.
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE (2011)
Ruthenium(II)-Catalyzed Asymmetric Transfer Hydrogenation Using Unsymmetrical Vicinal Diamine-Based Ligands: Dramatic Substituent Effect on Catalyst Efficiency
Bo Zhang et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2011)
Synthesis and Structure of Ruthenium(IV) Complexes Featuring N-Heterocyclic Ligands with an N-H Group as the Hydrogen-Bond Donor: Hydrogen Interactions in Solution and in the Solid State
Josefina Diez et al.
INORGANIC CHEMISTRY (2011)
Pharmacokinetic study of sodium trans[tetrachlorobis(1H-indazole)-ruthenate (III)]/-indazole hydrochloride (1:1.1) (FFC14A) in patients with solid tumors
M.M. Henke et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: A crucial role of AMPK and mTOR pathways
Po-Cheng Chiang et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Ruthenium-based chemotherapeutics: are they ready for prime time?
Emmanuel S. Antonarakis et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Ruthenium-catalyzed synthesis of beta-oxo esters in aqueous medium: Scope and limitations
Victorio Cadierno et al.
GREEN CHEMISTRY (2010)
Is the Reactivity of M(II)-Arene Complexes of 3-Hydroxy-2(1H)-pyridones to Biomolecules the Anticancer Activity Determining Parameter?
Muhammad Hanif et al.
INORGANIC CHEMISTRY (2010)
Rational Design of Highly Cytotoxic η6-Arene,β-Diketiminato-Ruthenium Complexes
Andrew D. Phlllips et al.
ORGANOMETALLICS (2010)
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
Frederike Lentz et al.
ANTI-CANCER DRUGS (2009)
Copper(II) complexes of mono-anionic glutamate: anionic influence in the variations of molecular and supramolecular structures
Chaitali Biswas et al.
DALTON TRANSACTIONS (2009)
Switching between κ2 and κ3 Bis(pyrazol-1-yl)acetate Ligands by Tuning Reaction Conditions: Synthesis, Spectral, Electrochemical, Structural, and Theoretical Studies on Arene-Ru(II) Derivatives of Bis(azol-1-yl)acetate Ligands
Fabio Marchetti et al.
INORGANIC CHEMISTRY (2009)
Mitochondrial function and energy metabolism in cancer cells: Past overview and future perspectives
Avraham Mayevsky
MITOCHONDRION (2009)
Platinum neurotoxicity pharmacogenetics
Sarah R. McWhinney et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Recent developments in ruthenium anticancer drugs
Aviva Levina et al.
METALLOMICS (2009)
Pincer CNN Ruthenium(II) Complexes with Oxygen-Containing Ligands (O2CR, OAr, OR, OSiR3, O3SCF3): Synthesis, Structure, and Catalytic Activity in Fast Transfer Hydrogenation
Walter Baratta et al.
ORGANOMETALLICS (2009)
Mitochondria as targets for cancer chemotherapy
Vladimir Gogvadze et al.
SEMINARS IN CANCER BIOLOGY (2009)
Aluminum Compounds Containing eta(1-) and/or eta(5)-Bidentate Dianionic Pyrrolyl-Methylamide Ligands
Ya-Chi Chen et al.
CHEMISTRY-A EUROPEAN JOURNAL (2008)
Synthesis and Intramolecular and Interionic Structural Characterization of Half-Sandwich (Arene)Ruthenium(II) Derivatives of Bis(Pyrazolyl)Alkanes
Fabio Marchetti et al.
INORGANIC CHEMISTRY (2008)
Cationic half-sandwich complexes (Rh, Ir, Ru) containing 2-substituted-1,8-naphthyridine chelating ligands: Syntheses, X-ray structure analyses and spectroscopic studies
Kota Thirumala Prasad et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2008)
Synthesis, reactivity, spectroscopic characterization, X-ray structures, PGSE, and NOE NMR studies of (η5-C5Me5)-rhodium and -iridium derivatives containing bis(pyrazolyl)alkane ligands
Claudio Pettinari et al.
INORGANIC CHEMISTRY (2007)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells
Keiran S. M. Smalley et al.
CANCER RESEARCH (2007)
Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) η6-arene imidazole complexes
Carsten A. Vock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Ruthenium mediated C-H activation of 2-(arylazo)phenols: Characterization of an intermediate and the final organoruthenium complex
P Gupta et al.
INORGANIC CHEMISTRY (2006)
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes
C Scolaro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175
RL Hayward et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Modifications of DNA by platinum complexes - Relation to resistance of tumors to platinum antitumor drugs
V Brabec et al.
DRUG RESISTANCE UPDATES (2005)
Association of active caspase 8 with the mitochondrial membrane during apoptosis: Potential roles in cleaving BAP31 and caspase 3 and mediating mitochondrion-endoplasmic reticulum cross talk in etoposide-induced cell death
D Chandra et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
Platinum complex toxicity in cultured renal epithelia
T Ludwig et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2004)
Use of chelating ligands to tune the reactive site of half-sandwich ruthenium(II)-arene anticancer complexes
R Fernández et al.
CHEMISTRY-A EUROPEAN JOURNAL (2004)
Formation of platinated GG cross-links on DNA by photoactivation of a platinum(IV) azide complex
J Kaspárková et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2003)
Synthesis and structural characterization of mixed-sandwich complexes of rhodium(III) and iridium(III) with cyclopentadienyl and hydrotris(pyrazolyl)borate ligands
E Carmona et al.
ORGANOMETALLICS (2003)
Selective hydrogenation for fine chemicals: Recent trends and new developments
HU Blaser et al.
ADVANCED SYNTHESIS & CATALYSIS (2003)
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer
RE Aird et al.
BRITISH JOURNAL OF CANCER (2002)
Synthesis, crystal structure and catalytic properties of (p-cymene)ruthenium(II) azophenol complexes:: azophenyl to azophenol conversion by oxygen insertion to a ruthenium-carbon bond
RK Rath et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2001)
Chemical control on the coordination mode of benzaldehyde semicarbazone ligands. Synthesis, structure, and redox properties of ruthenium complexes
F Basuli et al.
INORGANIC CHEMISTRY (2001)
Synthesis and characterization of bis(iminopyrrolyl)zirconium complexes
Y Matsuo et al.
CHEMISTRY LETTERS (2000)
Nitrogen-containing ligands for asymmetric homogeneous and heterogeneous catalysis
F Fache et al.
CHEMICAL REVIEWS (2000)
分享论文
